Case Report: Prolonged remission of metastatic cisplatin-refractory nasopharyngeal carcinoma with Pembrolizumab

Overview of attention for article published in Frontiers in oncology, November 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (57th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 20,052 followers.

Case Report: Prolonged remission of metastatic cisplatin-refractory nasopharyngeal carcinoma with Pembrolizumab FREE ARTICLE https://t.co/yldc5WsOgu

Case Report: Prolonged remission of metastatic cisplatin-refractory nasopharyngeal carcinoma with Pembrolizumab https://t.co/pqoeSmT0eC https://t.co/DCDCRBF1Gx

RT @FrontOncology: New research: Case Report: Prolonged remission of metastatic cisplatin-refractory nasopharyngeal carcinoma with Pembroli…

RT @FrontOncology: New research: Case Report: Prolonged remission of metastatic cisplatin-refractory nasopharyngeal carcinoma with Pembroli…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.